
- ONCOLOGY Vol 21 No 9
- Volume 21
- Issue 9
Integrins in Cancer: Novel Therapeutic Approaches
The integrins are a family of transmembrane receptors important for the cell-cell and cell-matrix interactions that relate to processes of cell adhesion, migration, invasion, angiogenesis, and survival.
The integrins are a family of transmembrane receptors important for the cell-cell and cell-matrix interactions that relate to processes of cell adhesion, migration, invasion, angiogenesis, and survival. The acquisition of integrins such as αvβ3 has been correlated to the process of tumor progression in multiple tissues, suggesting that approaches effectively targeting the integrins might inhibit or reverse progression. This supplement to ONCOLOGY, based on the symposium presented to the 31st Congress of the European Society of Medical Oncology on September 29, 2006, in Istanbul, updates information upon the current understanding of the integrins.
John M. Kirkwood, MD
Disclosures:
Dr. Kirkwood has acted as a consultant for MedImmune.
Articles in this issue
about 18 years ago
Advisory Committee Recommends FDA Wait for Satraplatin Survival Resultsabout 18 years ago
Red Wine Protects the Prostate, Seattle Investigators Reportabout 18 years ago
Key Developments in Rectal Cancer TreatmentNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.


















































































